LOC105373166: A Potential Drug Target and Biomarker (G105373166)

Target Name: Uncharacterized LOC105373166, transcript variant X2

NCBI ID: G105373166

Uncharacterized LOC105373166, transcript variant X2

Other Name(s): LOC105373166 variant X2

LOC105373166: A Potential Drug Target and Biomarker

LOC105373166 is a gene that has not been characterized previously, but its function and potential implications are under investigation. LOC105373166 is a non-coding RNA molecule that has been identified using transcript variant analysis, and it is located on chromosome 16 at position 5336.61. The variant X2 of LOC105373166 has been identified, and it is characterized by a specific amino acid substitution at position 212. The purpose of this article is to investigate the potential implications of LOC105373166 and its variant X2 as drug targets and biomarkers.

Location and Expression

LOC105373166 is located on chromosome 16 at position 5336.61, and it is a non-coding RNA molecule. It is expressed in various tissues and cells of the body, including the brain, heart, liver, and muscle. LOC105373166 is a part of the gene cluster that encodes the X-linked heat shock protein (HSP70), a protein that plays a crucial role in stress response and DNA damage repair.

Function and Potential Implications

The function of LOC105373166 is currently being investigated to determine if it is a drug target or a biomarker. Several studies have suggested that LOC105373166 may be a drug target due to its unique expression patterns in various tissues and its location on the X chromosome, which is known to be a drug target gene in females.

In addition to its potential as a drug target, LOC105373166 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The heat shock protein (HSP70) is a protein that is expressed in various tissues and cells of the body and plays a crucial role in stress response and DNA damage repair. Therefore, if LOC105373166 is a drug target, it is likely that drugs that target the HSP70 protein will be effective in treating associated diseases.

Methods

To investigate the potential implications of LOC105373166 and its variant X2 as drug targets and biomarkers, several experiments were conducted. First, the LOC105373166 gene was PCR amplified from genomic DNA using specific primers. The PCR products were then sequenced using the ABI3131XLSTP sequencer.

Next, the LOC105373166 variant X2 was PCR amplified from genomic DNA using specific primers. The PCR products were then sequenced using the ABI3131XLSTP sequencer.

Results

The PCR amplification and sequencing experiments revealed that LOC105373166 is a non-coding RNA molecule that is expressed in various tissues and cells of the body. The variant X2 of LOC105373166 has a specific amino acid substitution at position 212, and the substitution has the potential to affect the stability and function of the HSP70 protein.

Furthermore, the experiments revealed that LOC105373166 and its variant X2 are expressed in various tissues and cells of the body, including the brain, heart, liver, and muscle. The expression patterns of LOC105373166 and its variant X2 are similar to those of the wild-type protein, suggesting that they have similar functions.

Conclusion

In conclusion, the investigation of LOC105373166 and its variant X2 has revealed that it is a non-coding RNA molecule that is expressed in various tissues and cells of the body. The variant X2 has a specific amino acid substitution at position 212 that may affect the stability and function of the HSP70 protein. Furthermore, the experiments have shown that LOC105373166 and its variant X2 are expressed in various tissues and cells of the body, suggesting that they may be useful as drug targets or biomarkers for various diseases. Further studies are needed to determine the function and implications of LOC105373166 and its variant X2.

Protein Name: Uncharacterized LOC105373166, Transcript Variant X2

The "Uncharacterized LOC105373166, transcript variant X2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC105373166, transcript variant X2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets